This Tiny Plastic Implant May Disrupt America’s Opioid Addiction Problem

Motherboard by Vice, November 15, 2016. “I think the big issue is the transition,” said Diana Zuckerman, NCHR President, who was not involved with the trials. “People are going to go from taking pills to using this implant. The implant doesn’t work immediately. It takes a while for it to work and settle into the level that it’s supposed to be. And during that time the person is still going to be taking pills, and that becomes a vulnerable time. How many pills should that person take before the implant is really working, and should they continue to take pills after it’s working?“

Read More »

After Years of Criticism, FDA Tries to Step Up Oversight of Medical Devices

ConsumerAffairs, October 27, 2016. Diana Zuckerman, President of the National Center for Health Research, said about the FDA’s new site soliciting allegations of abuse in the medical device industry: “[W]ill it make a difference? Will the FDA finally stop treating device companies like their favorite customers and remember that patients and consumers are their most important customers? …More importantly, will FDA finally decide that they will no longer allow device companies to ignore patient safety?”

Read More »

Public Can Report Medical Device Problems at New FDA Webpage

Star Tribune, October 25, 2016. The U.S. Food and Drug Administration has set up a new webpage where the public can report allegations of regulatory misconduct against medical device makers and marketers. “This is a good idea, but the question is: what resources will the Center [for Devices and Radiological Health] devote to this to ensure that the allegations of misconduct are followed up and dealt with accordingly?” asked Diana Zuckerman, president of the National Center for Health Research.

Read More »